Clinical Study
Hypertension Control and Cardiometabolic Risk: A Regional Perspective
Table 2
Blood pressure and BMI (kg/m2; mean ± SE; adjusted for age, gender).
| | Total
() | Northern Europe
() | Southern Europe
() | North America
() | Midde East
() | Asia
() | value |
| | SBP (mmHg) | | | | | | | | | <120 | 28.2 (0.249) | 29.1 (0.487) | 28.4 (0.453) | 30.1 (0.601) | 28.3 (1.467) | 26.2 (0.474) | <0.0001 | | 120–139 | 28.5 (0.086) | 29.1 (0.168) | 28.6 (0.132) | 30.4 (0.253) | 31.0 (0.647) | 26.4 (0.187) | <0.0001 | | 140–159 | 28.8 (0.066) | 29.6 (0.108) | 29.0 (0.102) | 30.2 (0.222) | 29.7 (0.370) | 25.7 (0.158) | <0.0001 | | 160–179 | 29.5 (0.105) | 30.2 (0.169) | 29.9 (0.165) | 30.2 (0.403) | 29.6 (0.474) | 25.7 (0.287) | <0.0001 | | ≥180 | 29.5 (0.163) | 30.2 (0.249) | 30.2 (0.264) | 29.1 (0.763) | 30.0 (0.629) | 25.5 (0.445) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0126 | <0.0001 | | | DBP (mmHg) | | | | | | | | | <90 | 28.5 (0.063) | 29.3 (0.110) | 28.6 (0.102) | 29.9 (0.176) | 29.7 (0.440) | 26.0 (0.144) | <0.0001 | | 90–99 | 29.2 (0.082) | 30.1 (0.134) | 29.4 (0.124) | 30.5 (0.342) | 29.5 (0.395) | 25.7 (0.207) | <0.0001 | | 100–109 | 29.5 (0.113) | 30.0 (0.187) | 30.2 (0.169) | 31.5 (0.548) | 30.4 (0.471) | 25.9 (0.276) | <0.0001 | | ≥110 | 30.3 (0.227) | 30.8 (0.362) | 31.0 (0.350) | 31.9 (1.286) | 30.6 (0.793) | 26.3 (0.642) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0157 | <0.0001 | | | RR (mmHg) | | | | | | | | | uncontrolled* | 29.4 (0.066) | 29.9 (0.085) | 29.5 (0.082) | 30.1 (0.190) | 29.8 (0.259) | 25.7 (0.132) | <0.0001 | | controlled** | 28.6 (0.061) | 28.9 (0.170) | 28.4 (0.134) | 30.3 (0.239) | 30.6 (0.650) | 26.2 (0.184) | <0.0001 | | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0080 | <0.0001 | |
|
|
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.
|
